Qilian International Holding Group company info

What does Qilian International Holding Group do?
Qilian International Holding Group (NASDAQ:QLI) is a diversified company focused on the development, manufacture, and sales of pharmaceutical and chemical products. With operations based in China, Qilian International extends its expertise across areas such as licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD), and heparin products, aiming to cater to a broad range of healthcare needs. The company's projects span from the extraction and processing of raw materials to the development of innovative healthcare solutions, reflecting a commitment to high-quality products and the well-being of its customers. Qilian International's objectives are anchored in expanding its market presence, pioneering research and development in the pharmaceutical and chemical sectors, and driving sustainable growth while maintaining environmental stewardship.
Qilian International Holding Group company media
Company Snapshot

Is Qilian International Holding Group a public or private company?

key
Ownership
Public

How many people does Qilian International Holding Group employ?

people
Employees
298

What sector is Qilian International Holding Group in?

pie chart
Sector
Health Care

Where is the head office for Qilian International Holding Group?

location pin
Head Office
Shanghai, China

What year was Qilian International Holding Group founded?

founded flag
Year Founded
2019
What does Qilian International Holding Group specialise in?
/E-Commerce Platform /Commodity Trading /Financial Services /Supply Chain Management /Agricultural Products /Technology Development

What are the products and/or services of Qilian International Holding Group?

Overview of Qilian International Holding Group offerings
Licensing of Traditional Chinese Medicine derivatives for various health conditions, enhancing accessibility and effectiveness globally.
Development of Jitai Tablets, addressing opioid withdrawal symptoms and assisting in addiction recovery.
Manufacture and supply of high-quality heparin products, critical for blood anticoagulation treatments worldwide.
Innovative formulations of Osteoarthritis treatments, providing pain relief and improved joint function.
Production of silymarin, a natural liver protection compound, supporting liver health and detoxification.
Advanced API (Active Pharmaceutical Ingredients) processing capabilities, ensuring purity and efficacy for pharmaceutical industry partners.

Who is in the executive team of Qilian International Holding Group?

Qilian International Holding Group leadership team
  • Mr. Zhanchang  Xin
    Mr. Zhanchang Xin
    Chairman of the Board, President, CEO, COO & Chief Scientific Officer
  • Ms. Haiping  Shi
    Ms. Haiping Shi
    Chief Financial Officer
  • Mr. Dingqian  Liu
    Mr. Dingqian Liu
    Executive Director